高强度聚焦超声(HIFU)消融良性甲状腺结节过程中观察到的强回声标记的意义
本研究分析了136例接受HIFU消融的良性甲状腺结节患者,发现治疗中出现强回声标记(HEMs)的患者6个月体积缩小率(VRR)显著高于未出现者(65.76% vs 36.76%,p<0.001),且HEMs出现是治疗成功的独立预测因素(OR 275.44,95%CI 26.63-2848.98,p<0.001)。
要点
- HIFU消融良性甲状腺结节时出现强回声标记(HEMs)与6个月结节体积缩小率更高相关。
- 出现HEMs的患者6个月VRR为65.76%,未出现者为36.76%,差异有统计学意义(p<0.001)。
- HEMs出现是治疗成功(VRR≥50%)的独立预测因素(OR 275.44,95%CI 26.63-2848.98)。
核心结论
- 治疗过程中出现强回声标记(HEMs)是单次HIFU消融良性甲状腺结节后治疗成功的独立决定因素。
研究设计与样本
- 研究纳入136例接受HIFU治疗的良性甲状腺结节患者,由独立人员在每次脉冲后于B型超声屏幕上仔细观察HEMs的出现;计算HEMs比例(出现HEMs的脉冲数/总脉冲数×100%),并以体积缩小率(VRR)评估6个月时的结节缩小程度,治疗成功定义为VRR≥50%。
关键影像表现/征象
- 治疗过程中在B型超声上观察到的强回声标记(HEMs)表现为每次脉冲后出现的强回声。
- 出现HEMs的患者(n=91)6个月VRR为65.76%,未出现HEMs的患者(n=45)为36.76%,前者显著大于后者(p<0.001)。
诊断标准与关键数值
- 治疗成功定义为VRR≥50%,VRR=[(基线体积-6个月时体积)/基线体积]×100%。
- HEMs比例(%)=(出现HEMs的脉冲数/每次治疗给予的总脉冲数)×100%。
- 回归分析中,调整年龄和每脉冲能量后,基线结节体积较小(OR 1.143,95%CI 1.038-1.256,p=0.006)和出现HEMs(OR 275.44,95%CI 26.63-2848.98,p<0.001)是治疗成功的独立预测因素。
临床应用与阅片要点
- HIFU是良性甲状腺结节的一种安全有效的治疗方法。
- 较低的BMI和较大的施加功率增加强回声标记出现的可能性。
- HIFU治疗过程中强回声标记的出现影响后续治疗结果。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: To examine the association between the appearance of hyperechoic marks (HEMs) during high-intensity focused ultrasound (HIFU) ablation of benign thyroid nodules and nodule shrinkage at 6 months.
METHODS: One hundred and thirty-six patients who underwent HIFU for benign thyroid nodule were analysed. An independent person carefully examined the B-mode ultrasonography screen for the appearance of HEMs after each pulse. The proportion of HEMs (%) was calculated by: [(Number of pulses that resulted in HEMs) / (Total number of pulses given per treatment) × 100] while the nodule shrinkage was measured by volume reduction ratio (VRR) = [Baseline volume-volume at 6 months]/[Baseline volume] * 100. Treatment success was defined as VRR ≥ 50 %.
RESULTS: Patients with HEMs (n=91) had significantly greater 6-month VRR than those without HEMs (n=45) (65.76 % vs. 36.76 %, p<0.001). By regression analysis, after adjusting for age and energy per pulse, smaller nodule volume at baseline (OR 1.143, 95 % CI 1.038-1.256, p=0.006) and appearance of HEMs (OR 275.44, 95 % CI 26.63-2848.98, p<0.001) were independent predictors for treatment success.
CONCLUSIONS: The appearance of HEMs during treatment was an independent determinant of treatment success following single-session HIFU ablation of benign thyroid nodule.
KEY POINTS: • HIFU is a safe and effective treatment for benign thyroid nodules. • Lower BMI and greater applied power increase likelihood of hyperechoic marks. • The appearance of hyperechoic marks during HIFU affects subsequent treatment outcome.
引用
- Lang BHH, Woo YC, Chiu KW, et al. Significance of hyperechoic marks observed during high-intensity focused ultrasound (HIFU) ablation of benign thyroid nodules. Eur Radiol. 2018. PMID: 29313120. doi:10.1007/s00330-017-5207-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。